OXFORD, England, October 30, 2025--(BUSINESS WIRE)--ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE ® SL Self-Loading MHC Class I ...

OXFORD, England & EDINBURGH, Scotland--(BUSINESS WIRE)--ProImmune Ltd, a global leader in immunological reagents and services, today announced a collaboration with the University of Edinburgh’s Roslin ...

OXFORD, England, November 18 ProImmune Ltd, a leadingprovider of quality research reagents for monitoring the immune system andepitope discovery, has today announced the introduction of the ...

OXFORD, England, September 24 ProImmune Ltd., a leadingprovider of quality research reagents for monitoring the immune system andservices for antigen discovery, has announced the launch of its ...

ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a ...

The MarketWatch News Department was not involved in the creation of this content. -- Symposium brings together global leaders in immunogenicity to connect with China's rapidly evolving pharmaceutical ...

ProImmune has announced the introduction of MutaMap™, a new high-throughput assay service for understanding the impact of point mutations on protein therapeutic activity, including monoclonal ...

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE ® SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ T ...

Partnership will validate high quality, species-specific Ankyron binders for key animal health science applications, including prevention and monitoring of zoonotic diseases ProImmune Ltd, a global ...

Symposium brings together global leaders in immunogenicity to connect with China’s rapidly evolving pharmaceutical development landscape Speakers include thought leaders in biotherapeutics, complex ...

Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments ProImmune, Ltd., a global leader in immunological reagents and ...